241 related articles for article (PubMed ID: 33334877)
1. Cholesterol stimulates the cellular uptake of L-carnitine by the carnitine/organic cation transporter novel 2 (OCTN2).
Zhang L; Gui T; Console L; Scalise M; Indiveri C; Hausler S; Kullak-Ublick GA; Gai Z; Visentin M
J Biol Chem; 2021; 296():100204. PubMed ID: 33334877
[TBL] [Abstract][Full Text] [Related]
2. Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney.
Tamai I; China K; Sai Y; Kobayashi D; Nezu J; Kawahara E; Tsuji A
Biochim Biophys Acta; 2001 Jun; 1512(2):273-84. PubMed ID: 11406104
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in drug delivery via the organic cation/carnitine transporter 2 (OCTN2/SLC22A5).
Kou L; Sun R; Ganapathy V; Yao Q; Chen R
Expert Opin Ther Targets; 2018 Aug; 22(8):715-726. PubMed ID: 30016594
[TBL] [Abstract][Full Text] [Related]
4. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2.
Tamai I; Ohashi R; Nezu J; Yabuuchi H; Oku A; Shimane M; Sai Y; Tsuji A
J Biol Chem; 1998 Aug; 273(32):20378-82. PubMed ID: 9685390
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1--a novel interacting partner of organic cation/carnitine transporter (Octn2): effect of protein kinase C on this interaction in rat astrocytes.
Czeredys M; Samluk Ł; Michalec K; Tułodziecka K; Skowronek K; Nałęcz KA
PLoS One; 2013; 8(12):e82105. PubMed ID: 24349196
[TBL] [Abstract][Full Text] [Related]
6. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.
Seth P; Wu X; Huang W; Leibach FH; Ganapathy V
J Biol Chem; 1999 Nov; 274(47):33388-92. PubMed ID: 10559218
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4 cells, an in vitro model of the blood-brain barrier.
Friedrich A; Prasad PD; Freyer D; Ganapathy V; Brust P
Brain Res; 2003 Apr; 968(1):69-79. PubMed ID: 12644265
[TBL] [Abstract][Full Text] [Related]
8. Plasma Membrane Cholesterol Regulates the Allosteric Binding of 1-Methyl-4-Phenylpyridinium to Organic Cation Transporter 2 (SLC22A2).
Hörmann S; Gai Z; Kullak-Ublick GA; Visentin M
J Pharmacol Exp Ther; 2020 Jan; 372(1):46-53. PubMed ID: 31624079
[TBL] [Abstract][Full Text] [Related]
9. Colistin is substrate of the carnitine/organic cation transporter 2 (OCTN2, SLC22A5).
Visentin M; Gai Z; Torozi A; Hiller C; Kullak-Ublick GA
Drug Metab Dispos; 2017 Dec; 45(12):1240-1244. PubMed ID: 28986476
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter.
Console L; Scalise M; Tonazzi A; Giangregorio N; Indiveri C
Sci Rep; 2018 Feb; 8(1):3758. PubMed ID: 29491466
[TBL] [Abstract][Full Text] [Related]
11. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2.
Ohashi R; Tamai I; Nezu Ji J; Nikaido H; Hashimoto N; Oku A; Sai Y; Shimane M; Tsuji A
Mol Pharmacol; 2001 Feb; 59(2):358-66. PubMed ID: 11160873
[TBL] [Abstract][Full Text] [Related]
12. Maternal Plasma l-Carnitine Reduction During Pregnancy Is Mainly Attributed to OCTN2-Mediated Placental Uptake and Does Not Result in Maternal Hepatic Fatty Acid
Bai M; Zeng Q; Chen Y; Chen M; Li P; Ma Z; Sun D; Zhou H; Zheng C; Zeng S; Jiang H
Drug Metab Dispos; 2019 Jun; 47(6):582-591. PubMed ID: 30918014
[TBL] [Abstract][Full Text] [Related]
13. Clozapine-induced reduction of l-carnitine reabsorption via inhibition/down-regulation of renal carnitine/organic cation transporter 2 contributes to liver lipid metabolic disorder in mice.
Wang W; Bai M; Jiang T; Li C; Li P; Zhou H; Wang Z; Li L; Jiang H
Toxicol Appl Pharmacol; 2019 Jan; 363():47-56. PubMed ID: 30465787
[TBL] [Abstract][Full Text] [Related]
14. Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency.
Koleske ML; McInnes G; Brown JEH; Thomas N; Hutchinson K; Chin MY; Koehl A; Arkin MR; Schlessinger A; Gallagher RC; Song YS; Altman RB; Giacomini KM
Proc Natl Acad Sci U S A; 2022 Nov; 119(46):e2210247119. PubMed ID: 36343260
[TBL] [Abstract][Full Text] [Related]
15. Species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2).
Szabó K; Nagy Z; Juhász V; Zolnerciks JK; Csorba A; Tímár Z; Molnár É; Pádár P; Johnson W; Beéry E; Krajcsi P
Drug Metab Pharmacokinet; 2017 Jun; 32(3):165-171. PubMed ID: 28365301
[TBL] [Abstract][Full Text] [Related]
16. beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter.
Ganapathy ME; Huang W; Rajan DP; Carter AL; Sugawara M; Iseki K; Leibach FH; Ganapathy V
J Biol Chem; 2000 Jan; 275(3):1699-707. PubMed ID: 10636865
[TBL] [Abstract][Full Text] [Related]
17. Involvement of carnitine/organic cation transporter OCTN2 (SLC22A5) in distribution of its substrate carnitine to the heart.
Iwata D; Kato Y; Wakayama T; Sai Y; Kubo Y; Iseki S; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(3):207-15. PubMed ID: 18574325
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine residues affecting sodium stimulation of carnitine transport in the OCTN2 carnitine/organic cation transporter.
Amat di San Filippo C; Longo N
J Biol Chem; 2004 Feb; 279(8):7247-53. PubMed ID: 14665638
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation of the OCTN2 carnitine transporter: study of natural mutations identified in patients with primary carnitine deficiency.
Filippo CA; Ardon O; Longo N
Biochim Biophys Acta; 2011 Mar; 1812(3):312-20. PubMed ID: 21126579
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin transport mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons.
Jong NN; Nakanishi T; Liu JJ; Tamai I; McKeage MJ
J Pharmacol Exp Ther; 2011 Aug; 338(2):537-47. PubMed ID: 21606177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
